Phase 1 study in Staphylococcus aureus endocarditis
This research study is about a severe heart infection called Staphylococcus aureus endocarditis. This infection happens when a type of bacteria, called 'staph,' gets into the bloodstream and settles on the heart valves, causing serious damage. Currently, treating this condition can be very challenging. This study is the earliest stage of testing a new treatment in humans, known as a Phase 1 study. The main goal at this stage is to check if the new treatment is safe for people and how it acts in the body. It's an important step in finding better ways to help patients with this difficult infection. Participants must be at least 18 years old, and the study is open to both men and women.
At a glance
What is this study about?
This study is focused on a serious health problem called Staphylococcus aureus endocarditis. To break it down, 'Staphylococcus aureus' is a common type of bacteria, often called 'staph.' 'Endocarditis' means an infection of the inner lining of your heart, especially your heart valves. When staph bacteria get into your bloodstream and attack these heart valves, it can cause severe damage and be very difficult to treat, sometimes leading to life-threatening complications.
The main purpose of this research is to test a brand new treatment for this serious infection. This is a very early stage of human testing, called a Phase 1 study. In this first phase, doctors are primarily looking to see if the new treatment is safe for people to take and how the body handles it. They're not yet trying to prove if it works better than existing treatments, but rather to understand its basic effects and safety profile.
Finding new and effective treatments for Staphylococcus aureus endocarditis is really important because current options don't always work for everyone and can have side effects. By carefully studying this new treatment now, researchers hope to gather crucial information that could, in the future, lead to better ways to help patients with this challenging heart infection.
Key takeaways
- It's an early-stage study (Phase 1) researching a new treatment for a serious heart infection.
- The primary goal is to check the treatment's safety and how the body reacts to it.
- Participants must be 18 years or older, both men and women are welcome.
- Joining involves regular clinic visits for treatment and health checks.
- Participation is voluntary, and you can withdraw at any time.
Who may be eligible?
To be considered for this study, you must be an adult aged 18 years or older. There is no upper age limit, meaning older adults are also welcome to participate.
Both men and women are invited to take part in this research. The study needs participants of all genders to understand how the new treatment might affect different people.
Beyond these basic requirements, there will be other specific health checks and criteria that the study doctors will need to review to make sure this study is safe and appropriate for you. They will explain all of this in detail if you are interested.
Could this study suit you?
Answer these quick questions to see if you may be eligible. This is a guide only — the research team makes the final call.
- Are you 18 years old or older?
- Are you a man or a woman?
- Have you been diagnosed with Staphylococcus aureus endocarditis?
- Are you able to attend regular clinic appointments?
What does participation involve?
Taking part in this study would involve several visits to the clinic so the medical team can closely monitor your health. You would receive the investigational treatment, which is the new therapy being tested, according to a schedule set by the study doctors. During these visits, nurses and doctors would carry out various assessments, such as blood tests, physical examinations, and possibly heart scans, to check your safety and how your body is responding to the treatment.
After you have received the treatment, there will be follow-up appointments to continue monitoring your health for a period. The total length of your participation, including all treatment and follow-up, will be clearly explained to you before you make any decision to join. You will be given all medications related to the study, and you will have the opportunity to ask questions at every step.
Potential risks and benefits
Locations (1)
- —UnverifiedFrance
Common questions
What exactly is 'Staphylococcus aureus endocarditis'?
It's a serious heart infection caused by a common type of bacteria called 'staph.' The bacteria infect the inner lining of your heart, often the heart valves.
Why is this study being done?
This study is looking for new and safer ways to treat this serious heart infection, which can be very difficult to manage with current treatments.
What does 'Phase 1' mean for a study?
Phase 1 is the very first time a new treatment is tested in people. The main goal is to check how safe it is and how the body handles it, rather than if it definitely cures the illness.
Who can take part in this study?
Adults aged 18 and over, both men and women, are potentially eligible. The study doctors will do further checks to make sure it's suitable for you.
Will I get the new treatment if I join?
Yes, if you meet all the requirements and decide to join, you would receive the new treatment being investigated in this study.
How to find out more
Always speak to your GP or specialist before deciding to take part in a study.
Discussion
Community discussion
Powered by our forum at community.patient.info. Please be respectful — this is not medical advice.